Ortho-Clinical Diagnostics

Type: Company
Name: Ortho-Clinical Diagnostics
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

MEDCOMTECH : Combine Solicitation - 65-- Traditional and ID-MTS Gel Testing Supplies

Notice Type: Combine SolicitationPosted Date: 16-SEP-14Office Address: Department of the Army ; U.S. Army Medical Command; MEDCOM , North Atlantic Regional Contracting Office; Medcom Contracting Center North Atlantic, ATTN: MCAA NA Bldg T20, 6900 Georgia ... [Published 4 Traders - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Milestone moment at Sphere Medical with flagship launch

Sphere Medical reached a major company milestone today in what has been a momentous year for the medical devices firm when it announced its pioneering blood gas analyser, Proxima 3, would see its commercial launch this week.Used with patients in critical ... [Published Cabume - Sep 17 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Johnson & Johnson's Management Presents at 2014 Morgan Stanley Health Care Conference (Transcript)

David Lewis - Morgan StanleyGood morning. It’s a, sorry. So find your seats here. It’s our pleasure to have this year this morning management team members from Johnson & Johnson, specifically the Chief Financial Officer, Dominic Caruso; so Stan Panasewicz, ... [Published Seeking Alpha - Sep 10 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 2 reports

Astute Medical to Release First Test for Risk Assessment of Kidney Injury

SAN DIEGOAstute Medical, Inc. announced today that it has received 510(k) clearance through the Food and Drug Administration's (FDA's) de novo classification process for its first biomarker-based immunoassay known as the NephroCheck® Test System, clearing ... [Published Bio-Medicine - Sep 08 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

First Dx for kidney failure approved by FDA

The FDA cleared the first and only diagnostic for acute kidney injury (also called acute renal failure) today, Astute Medical announced. A recent study found that hospitalized patients who got AKI had a 30% mortality rate at one year, twice that of a ... [Published FierceMedicalDevices - Sep 08 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Conyers advises The Carlyle Group on $4bn acquisition of Ortho-Clinical Diagnostics

5 September 2014Conyers Dill & Pearman has provided Bermuda legal advice to The Carlyle Group in relation to the acquisition of Ortho-Clinical Diagnostics (OCD ) for approximately $4bn (£2.5bn). OCD, formerly a subsidiary of Johnson & Johnson, is a provider ... [Published The Lawyer - Sep 05 2014]
First reported Sep 04 2014 - Updated Sep 05 2014 - 2 reports

Future Horizons and Growth Strategies in the Global Flow Cytometry Market 2014: Supplier Shares and Country Forecasts

Research and Markets (http://www.researchandmarkets.com/research/r8nnxx/future_horizons) has announced the addition of the "" report to their offering. This 7-country report will help current suppliers and potential market entrants identify and evaluate ... [Published Individual.com - Sep 04 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 2 reports

Johnson & Johnson looks to sell medical device business

Johnson & Johnson  is seeking a buyer for its medical device maker business, Cordis, according to the Wall St Journal.The sale of Cordis – which is still at an early stage - could fetch between $1.5 billion and $2 billion, a contact told the Journal.Cordis ... [Published Medical Plastics News - Sep 03 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Why J&J Wants to Divest Medical Devices Business

Big old-school conglomerates are selling. First it was Dow Chemical, Merck and General Electric putting up units for sale. Now its Johnson & Johnson, the world’s biggest maker of health-care products, that is seeking a buyer for its medical devices b ... [Published Yahoo! Finance - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson

In a report published Friday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Johnson & Johnson (NYSE: JNJ[1]).In the report, Morgan Stanley noted, “The Wall Street Journal is reporting that J&J is seeking a buyer for Cordis, ... [Published DailyMe.Com - Aug 29 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson

In a report published Friday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Johnson & Johnson (NYSE: JNJ).In the report, Morgan Stanley noted, “The Wall Street Journal is reporting that J&J is seeking a buyer for Cordis, a ... [Published Benzinga.com - Aug 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 3 reports

Astute Medical And Ortho-Clinical Diagnostics Enter Strategic Collaboration To Advance Innovative Acute Kidney Injury Test

SAN DIEGO, July 28, 2014 /PRNewswire/ -- Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury ... [Published PR Newswire: Health - Jul 28 2014]

Quotes

...are delighted to announce the commercial launch of Proxima in to the UK market, our first marketed product," said Rencken in a company statement. "Frequent measurement of arterial blood samples is a key component in the effective management of patients in the critical care environment, particularly those that are unstable. Proxima keeps the care giver by the patient, conserves blood and rapidly returns blood gas results to aid early decision making and closer control of therapy for critically ill patients – all of which ultimately improve patient outcomes."
"I think the type of startups that medtechs are going to be interested in is fundamentally going to change," Babitt said. "Medtech is going to look for service offerings, so they are going to look for technology offerings. They are not going to look for a femoral closure device to round out their suite of interventional cardiology and cath lab products."
...patients who are critically ill and going into the ICU," Paul McPherson, chief scientific officer at Astute Medical, told Medical Device Daily. "Acute kidney injury is an abrupt decline in kidney function . . . major surgery patients, patients who have a heart valve replacement or coronary bypass can develop acute kidney injury, some antibiotics that are given to these patients can cause acute kidney injury. It is very difficult for physicians to figure out a patient is developing acute kidney injury because there are no early signs or symptoms . . . current lab tests often pick them up too late."
"Worldwide sales of $8.5 billion increased 21.1% with U S up 36.6% and sales outside the U S up 6.9% driven by both strong sales of new products as well as core growth products. A major driver was our recently launched hepatitis C product called OLYSIO in the U S and EU and SOVRIAD in Japan. Excluding sales of the hepatitis C products, OLYSIO and INCIVO, underlying growth worldwide, U S and outside the U S was approximately 10.5%, 15% and 6.5% respectively."

More Content

All (63) | News (37) | Reports (0) | Blogs (22) | Audio/Video (0) | Fact Sheets (1) | Press Releases (3)
sort by: Date | Relevance
MEDCOMTECH : Combine Solicitation - 65-- Tradit... [Published 4 Traders - Sep 17 2014]
Milestone moment at Sphere Medical with flagshi... [Published Cabume - Sep 17 2014]
UPDATE - Sphere Medical upbeat ahead of launch ... [Published Proactive Investors.co.uk - Sep 15 2014]
3 Trends Shaping The Evolving Medtech Market [Published Medical Device & Diagnostic Industry - Sep 12 2014]
Johnson & Johnson's Management Presents at 2014... [Published Seeking Alpha - Sep 10 2014]
FDA clears new biomarker test from Astute Medic... [Published Medical Device Daily - Sep 10 2014]
Johnson & Johnson: The One Stock You Should Eve... [Published Seeking Alpha - Sep 09 2014]
FDA OKs Astute Medical’s First Diagnostic for A... [Published Xconomy - Sep 09 2014]
Astute Medical Inc. Receives FDA Clearance for ... [Published San Diego Business Journal - Sep 08 2014]
NAMSR: NEWS- FDA Clears first ever diagnostic t... [Published Prlog - Sep 08 2014]
First Dx for kidney failure approved by FDA [Published FierceMedicalDevices - Sep 08 2014]
Astute Medical to Release First Test for Risk A... [Published Bio-Medicine - Sep 08 2014]
Astute Medical to Release First Test for Risk A... [Published Finwin - Sep 08 2014]
Conyers advises The Carlyle Group on $4bn acqui... [Published The Lawyer - Sep 05 2014]
Future Horizons and Growth Strategies in the Eu... [Published Individual.com - Sep 05 2014]
Future Horizons and Growth Strategies in the Gl... [Published Individual.com - Sep 04 2014]
Future Horizons and Growth Strategies in the UK... [Published Individual.com - Sep 04 2014]
Johnson & Johnson looks to sell medical device ... [Published Medical Plastics News - Sep 03 2014]
Johnson & Johnson: Moving To Higher-Growth Tech... [Published Seeking Alpha - Sep 02 2014]
J&J plans to sell medical devices business Cordis [Published Medical Devices Business Review - Sep 02 2014]
Research and Markets: 2014 Opportunities in the... [Published TVNewsCheck - Sep 01 2014]
J&J looks to sell off Cordis for as much as $2B [Published FierceMedicalDevices - Aug 29 2014]
Why J&J Wants to Divest Medical Devices Business [Published Yahoo! Finance - Aug 29 2014]
Report: J&J puts Cordis on the block [Published MassDevice - Aug 29 2014]
Morgan Stanley Sees More Focused Device Strateg... [Published DailyMe.Com - Aug 29 2014]
Morgan Stanley Sees More Focused Device Strateg... [Published Benzinga.com - Aug 29 2014]
Johnson and Johnson Plans To Divest Its Cordis ... [Published Bidness Etc - Aug 29 2014]
Johnson & Johnson to seek buyer for medical dev... [Published CNBC - Aug 29 2014]
Future Horizons and Growth Strategies in the US... [Published Global Information Inc - Aug 26 2014]
3 Points Showing Why Medtech is Having a Great ... [Published Medical Device & Diagnostic Industry - Aug 20 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Carlyle: Europe, Japan Price Discount Too Great... [Published WSJ.com: Private Equity Beat - Jul 30 2014]
Carlyle Co-Founders and Co-Chief Executives William Conway (left) and David Rubenstein.Bloomberg News/Simon Dawson Carlyle Group LP, which has been investing capital more quickly this year than many of its peers, believes bargains lie in Europe and ...
Astute Medical And Ortho-Clinical Diagnostics E... [Published PR Newswire: Health - Jul 28 2014]
SAN DIEGO, July 28, 2014 /PRNewswire/ -- Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury ...
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Technology News - Jul 28 2014]
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. has entered into a strategic partnership with Astute Medical, Inc. to become the exclusive commercial partner of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter. ...
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published Business Wire Health News - Jul 28 2014]
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. has entered into a strategic partnership with Astute Medical, Inc. to become the exclusive commercial partner of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter. ...
Innovator Liability at 100 [Published Drug and Device Law - Jul 18 2014]
This post is only from the Reed Smith (more properly, the non-Dechert) side of the blog.One hundred what, you say?Certainly not years; the awful Conte v. Wyeth, Inc., 85 Cal. Rptr.3d 299, (Cal. App. 2008), decision just turned six – this blog is older ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Johnson & Johnson Completes Divestiture Of Orth... [Published Financial Services - Jun 30 2014]
Robert Yates to be Named Chief Operating Office... [Published GlobeNewswire: Acquisitions News - Jun 16 2014]
Johnson & Johnson Announces Acceptance Of Bindi... [Published Financial Services - Mar 31 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.